![John McQuaid](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
John McQuaid currently works at Almac Pharma Services Ltd., as President & Managing Director from 2022.
Actieve functies van John McQuaid
Bedrijven | Functie | Begin |
---|---|---|
Almac Pharma Services Ltd.
![]() Almac Pharma Services Ltd. Pharmaceuticals: MajorHealth Technology Part of The McClay Foundation, Almac Pharma Services Ltd. is a British company that provides a range of contract pharmaceutical development and manufacturing services. The company is based in Craigavon, UK. The company's services include adjudication of in-transit and clinical site excursions, compliance management of shipments & sites, and comprehensive GDP monitoring. The company also offers customised CDX solutions that are unique to companies worldwide. Almac Clinical Services has not experienced any significant operational impact due to the coronavirus outbreak and their service levels remain unchanged. John McQuaid has been the CEO of the company since 1994. | Algemeen Directeur | 04-10-2022 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Almac Pharma Services Ltd.
![]() Almac Pharma Services Ltd. Pharmaceuticals: MajorHealth Technology Part of The McClay Foundation, Almac Pharma Services Ltd. is a British company that provides a range of contract pharmaceutical development and manufacturing services. The company is based in Craigavon, UK. The company's services include adjudication of in-transit and clinical site excursions, compliance management of shipments & sites, and comprehensive GDP monitoring. The company also offers customised CDX solutions that are unique to companies worldwide. Almac Clinical Services has not experienced any significant operational impact due to the coronavirus outbreak and their service levels remain unchanged. John McQuaid has been the CEO of the company since 1994. | Health Technology |